a developer of proprietary, potentially curative therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.
Ticker / NAME | Correlation To NTLA | 1D Price Change % | ||
---|---|---|---|---|
NTLA | 100% | -3.24% | ||
EDIT - NTLA | 74% Closely correlated | -3.58% | ||
BEAM - NTLA | 67% Closely correlated | -1.57% | ||
CRSP - NTLA | 63% Loosely correlated | -1.85% | ||
PRME - NTLA | 58% Loosely correlated | -8.33% | ||
DNLI - NTLA | 56% Loosely correlated | -0.87% | ||
More |
Ticker / NAME | Correlation To NTLA | 1D Price Change % |
---|---|---|
NTLA | 100% | -3.24% |
NTLA (5 stocks) | 82% Closely correlated | -6.40% |
drugs (254 stocks) | 62% Loosely correlated | -1.72% |
therapeutics (53 stocks) | 51% Loosely correlated | -2.44% |
biotechnology (238 stocks) | 41% Loosely correlated | -1.80% |